Bio & Insurance Information

Dr. Andrew Hendifar is a specialist in medical oncology based in Los Angeles, California and he is working in collaboration with many regional hospitals, such as Cedars-Sinai Medical Center and Keck Medical Center of USC. He graduated from Tulane University School of Medicine where he got his medical degree. He completed his residency program in internal medicine at the University of Southern California - LAC+USC Medical Center. He did two fellowships, one in medical oncology and one in hematology, both of them at University of Southern California - LAC+USC Medical Center. The doctor is board certified in hematology, internal medicine, and medical oncology and he has been practicing for more than 20 years.


Education & Training

Tulane University School of Medicine

Medical School

University of Southern California - LAC+USC Medical Center

Residency

University of Southern California - LAC+USC Medical Center

Fellowship

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine - Hematology

American Board of Internal Medicine - Oncology

Hospitals & Clinics

Cedars-Sinai Medical Center

Languages: English/Spanish

(310) 423-3277

8700 Beverly Blvd

Los Angeles, California 90048

Read More

Keck Hospital of USC - Medical Center

Languages: English/Spanish

(323) 442-8500

1500 San Pablo St

Los Angeles, California 90033

Read More

Providence Saint John's Health Center

Languages: English/Spanish

(310) 829-5511

2121 Santa Monica Boulevard

Santa Monica, California 90404

Read More

Ronald Reagan UCLA Medical Center

Languages: English/Spanish

(310) 825-9111

757 Westwood Plaza

Los Angeles, California 90095

Read More

Publications

Dr. Andrew E. Hendifar has contributed to 3 publications.

Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy.

Osipov, A.,Naziri, J.,Hendifar, A.,Dhall, D.,Rutgers, J. K.,Chopra, S.,Li, Q.,Tighiouart, M.,Annamalai, A.,Nissen, N. N.,Tuli, R.; J Gastrointest Oncol. 2016 Apr 02.

See more >>

Meta-analyses of treatment standards for pancreatic cancer.

Gong, J.,Tuli, R.,Shinde, A.,Hendifar, A. E.; Mol Clin Oncol. 1900 Jan 01.

See more >>

Biomarker-driven EGFR therapy improves outcomes in patients with metastatic colorectal cancer.

Hendifar, A.,Tan, C. R.,Annamalai, A.,Tuli, R.; Expert Rev Anticancer Ther. 2014 Jun 06.

See more >>

Memberships

American Society of Clinical Oncology